Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
12,980,577
-
Share change
-
+1,326,322
-
Total reported value
-
$121,887,208
-
Put/Call ratio
-
12%
-
Price per share
-
$9.39
-
Number of holders
-
65
-
Value change
-
+$12,525,355
-
Number of buys
-
39
-
Number of sells
-
21
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2014
As of 30 Jun 2014,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,980,577 shares.
The largest 10 holders included
BRIDGER MANAGEMENT, LLC, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Visium Asset Management, LP, BlackRock Fund Advisors, COLUMBUS CIRCLE INVESTORS, JENNISON ASSOCIATES LLC, TFS CAPITAL LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.